| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 1,243,000 | 788,000 | 644,000 | 860,000 | | Cost of Revenue | 654,000 | 593,000 | 321,000 | 349,000 | | | Gross Profit | 589,000 | 195,000 | 323,000 | 511,000 | | | Operating Expenses | | Research Development | 290,000 | 316,000 | 312,000 | 332,000 | | Selling General and Administrative | 292,000 | 278,000 | 230,000 | 190,000 | | Non Recurring | 100,000 | 6,000 | 14,000 | 39,000 | | Others | 14,000 | 12,000 | 12,000 | 12,000 | | | | Total Operating Expenses | 696,000 | 612,000 | 568,000 | 573,000 | | | | Operating Income or Loss | (107,000) | (417,000) | (245,000) | (62,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11,000) | (1,000) | (13,000) | 3,000 | | Earnings Before Interest And Taxes | (110,000) | (418,000) | (258,000) | (59,000) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (110,000) | (418,000) | (258,000) | (59,000) | | Income Tax Expense | (28,000) | (27,000) | (24,000) | (17,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (82,000) | (391,000) | (234,000) | (42,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (82,000) | (391,000) | (234,000) | (42,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($82,000) | ($391,000) | ($234,000) | ($42,000) |
|
0.35% Nasdaq 
Income Statement
